Canadian trials have just begun for a prospective coronavirus vaccine, but its Quebec-based manufacturer is already downplaying its potential impact, cautioning observers against holding unrealistic expectations that his product — or any of the numerous vaccines in development globally — will bring the pandemic to a screeching halt.
Be First to Comment